Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 70/100

Failure Rate

37.5%

6 terminated/withdrawn out of 16 trials

Success Rate

60.0%

-26.5% vs industry average

Late-Stage Pipeline

31%

5 trials in Phase 3/4

Results Transparency

56%

5 of 9 completed trials have results

Key Signals

5 with results

Enrollment Performance

Analytics

N/A
5(33.3%)
Phase 3
5(33.3%)
Phase 2
3(20.0%)
Phase 1
2(13.3%)
15Total
N/A(5)
Phase 3(5)
Phase 2(3)
Phase 1(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (16)

Showing 16 of 16 trials
NCT00426985Phase 3Terminated

Efficacy and Safety of Ketoprofen Topical Patch 20% in the Treatment of Pain Associated With Shoulder, Elbow or Knee Tendonitis or Bursitis

Role: lead

NCT06987773Phase 1Completed

Study on Sapropterin Dihydrochloride Oral Suspension in Healthy Subjects Under Fed Conditions

Role: lead

NCT05827536Not ApplicableTerminated

Open-label, Randomized, 2-way Crossover, Monocentric, Controlled Study to Evaluate the Effect on Daily PHE Fluctuation of PKU GOLIKE Versus SoC in Patients With PKU.

Role: lead

NCT05487378Not ApplicableCompleted

Evaluation of Phe Fluctuation in PKU Pts Treated With PKU GOLIKE Versus Standard Amino Acid Protein Substitute.

Role: lead

NCT06481709Phase 1Completed

Study on Sapropterin Dihydrochloride Oral Suspension in Healthy Subjects

Role: lead

NCT05499780Not ApplicableTerminated

Study on Performance and Safety of Sentinox in the Prevention of Acute Respiratory Infections (ARI)

Role: lead

NCT04311697Phase 2Completed

Intravenous Aviptadil for Critical COVID-19 With Respiratory Failure

Role: lead

NCT05229549Not ApplicableTerminated

Study to Evaluate the Effect on Nitrogen Retention of Two Different Posology Schemes of PKU GOLIKE PLUS 3-16 and Free AAs in Patients With Phenylketonuria

Role: lead

NCT04453839Unknown

ZYESAMI (Aviptadil) Intermediate Population Expanded Access Protocol (SAMICARE)

Role: lead

NCT04360096Phase 2Terminated

Inhaled ZYESAMI™ (Aviptadil Acetate) for the Treatment of Severe COVID-19

Role: lead

NCT05137795Phase 3Withdrawn

Inhaled ZYESAMI (Aviptadil Acetate) for Treatment of Severe COVID-19

Role: lead

NCT04909996Not ApplicableCompleted

Study on the Performance and Safety of Sentinox in COVID-19 Patients

Role: lead

NCT00365586Phase 3Completed

Ketoprofen Topical Patch, 20% in the Treatment of Pain Associated With Osteoarthritis Flare of the Knee

Role: lead

NCT00352625Phase 3Completed

Ketoprofen Topical Patch 20% in the Treatment of Pain Associated With Shoulder, Elbow or Knee Tendonitis or Bursitis

Role: lead

NCT00351104Phase 3Completed

Efficacy and Safety of Ketoprofen Topical Patch 20% in the Treatment of Pain Associated With Ankle Sprain or Strain

Role: lead

NCT00903994Phase 2Completed

A Pilot Study on the Onset of Action of KTP, 20% in the Treatment of Acute Pain Associated With Tendonitis or Bursitis of the Shoulder, Elbow or Knee

Role: lead

All 16 trials loaded